Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Kadmon Holdings Llc (KDMN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 351,541
  • Shares Outstanding, K 126,910
  • Annual Sales, $ 1,400 K
  • Annual Income, $ -54,250 K
  • 60-Month Beta 2.83
  • Price/Sales 269.09
  • Price/Cash Flow N/A
  • Price/Book 7.25

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.24
  • Growth Rate Est. (year over year) +416,350.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.52 +9.92%
on 02/25/19
3.08 -10.06%
on 03/22/19
+0.25 (+9.92%)
since 02/22/19
3-Month
1.88 +47.34%
on 12/31/18
3.08 -10.06%
on 03/22/19
+0.84 (+43.52%)
since 12/21/18
52-Week
1.88 +47.34%
on 12/31/18
4.52 -38.72%
on 03/23/18
-1.58 (-36.32%)
since 03/22/18

Most Recent Stories

More News
Kadmon Announces Susan Wiviott to Step Down from Board of Directors

NEW YORK, NY / ACCESSWIRE / March 22, 2019 / Kadmon Holdings, Inc. (NYSE: KDMN) today announced that Susan Wiviott does not intend to stand for re-election to Kadmon's Board of Directors at the upcoming...

KDMN : 2.77 (-6.42%)
Kadmon to Present at the Oppenheimer 29th Annual Healthcare Conference

NEW YORK, NY / ACCESSWIRE / March 13, 2019 / Kadmon Holdings, Inc. (NYSE: KDMN) today announced that Harlan W. Waksal, M.D., President and Chief Executive Officer, will present at Oppenheimer's 29th Annual...

KDMN : 2.77 (-6.42%)
Kadmon Provides Business Update and Reports Fourth Quarter and Full Year 2018 Financial Results

KDMN : 2.77 (-6.42%)
MGTX : 18.31 (-7.29%)
Biotechs Search for Innovative Methods to Combat Common Diseases

Medical conditions are universally prevalent around the world, especially in areas where people lack access to proper healthcare. The most common forms of deadly medical conditions are coronary artery...

BTHCF : 0.1880 (+1.62%)
PTI : 4.07 (-5.35%)
AGN.CN : 0.255 (+6.25%)
PRTO : 3.32 (+3.43%)
KDMN : 2.77 (-6.42%)
TCON : 1.47 (-0.68%)
Biotechnology Companies Ramp up Funding as Deadly Diseases Come Into the Spotlight

Biotechnology is rapidly and continually evolving each year with new innovative therapies and drugs. The companies within the industry are researching and developing new efficient ways to effectively treat...

BTHCF : 0.1880 (+1.62%)
CNAT : 1.28 (-56.01%)
AGN.CN : 0.255 (+6.25%)
RMTI : 5.79 (-8.96%)
AKBA : 8.39 (-3.56%)
KDMN : 2.77 (-6.42%)
Kadmon Announces Appointment of Steven Meehan as CFO

Kadmon Holdings, Inc. (NYSE: KDMN) today announced the appointment of Steven Meehan as Executive Vice President, Chief Financial Officer. Mr. Meehan, who has served as a member of the Board of Directors...

KDMN : 2.77 (-6.42%)
Kadmon Announces Appointment of David E. Cohen, M.D., MPH, to Board of Directors

Kadmon Holdings, Inc. (NYSE: KDMN) today announced the appointment of David E. Cohen, M.D., MPH, to its Board of Directors. Dr. Cohen has held a variety of positions at the New York University School of...

KDMN : 2.77 (-6.42%)
New Research: Key Drivers of Growth for Real Goods Solar, Standard Motor Products, Progress Software, Avon Products, Natus Medical, and Kadmon -- Factors of Influence, Major Initiatives and Sustained Production

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Real Goods Solar, Inc. (NASDAQ:RGSE),...

RGSE : 0.2904 (+0.14%)
SMP : 47.59 (-2.88%)
BABY : 25.20 (-6.25%)
KDMN : 2.77 (-6.42%)
PRGS : 35.82 (-3.58%)
AVP : 3.06 (+10.07%)
Kadmon Announces Appointment of Cynthia Schwalm to Board of Directors

Kadmon Holdings, Inc. (NYSE: KDMN) today announced the appointment of Cynthia Schwalm to its Board of Directors. Ms. Schwalm has extensive pharmaceutical industry experience, having held management roles...

KDMN : 2.77 (-6.42%)
Kadmon Announces Appointment of Tasos G. Konidaris as Interim Chairman of the Board

Kadmon Holdings, Inc. (NYSE: KDMN) today announced that Tasos G. Konidaris, a member of Kadmon's board of directors, has been appointed interim chairman, effective immediately. Mr. Konidaris has significant...

KDMN : 2.77 (-6.42%)
NVS : 93.42 (-0.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade KDMN with:

Business Summary

Kadmon Holdings, Inc. is a biopharmaceutical company. It engaged in the discovery, development and commercialization of small molecules and biologics to address disease areas of significant unmet medical need. The company is developing product candidates within autoimmune and fibrotic diseases, oncology...

See More

Key Turning Points

2nd Resistance Point 3.18
1st Resistance Point 2.98
Last Price 2.77
1st Support Level 2.67
2nd Support Level 2.56

See More

52-Week High 4.52
Fibonacci 61.8% 3.51
Fibonacci 50% 3.20
Fibonacci 38.2% 2.89
Last Price 2.77
52-Week Low 1.88

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar